AavantiBio Funding & Investors

Cambridge, MA

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Total Amount Raised: $107,000,000

AavantiBio Funding Rounds

Series A
$107,000,000
Oct 21, 2020
Series A Investors
Perceptive Advisors
Bain Capital Life Sciences
Sarepta Therapeutics
Ra Capital Management
SV Health Investors

Funding info provided by Diffbot.